GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 319 filers reported holding GW PHARMACEUTICALS PLC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $716,000 | -66.6% | 8,174 | -60.1% | 0.02% | -50.0% |
| Q4 2019 | $2,142,000 | +1.0% | 20,483 | +11.1% | 0.04% | +13.5% |
| Q3 2019 | $2,120,000 | +387.4% | 18,430 | +630.2% | 0.04% | +208.3% |
| Q2 2019 | $435,000 | -90.2% | 2,524 | -90.4% | 0.01% | -91.0% |
| Q1 2019 | $4,441,000 | -17.6% | 26,346 | -31.8% | 0.13% | -6.9% |
| Q2 2018 | $5,389,000 | +525.2% | 38,623 | +349.2% | 0.14% | +585.7% |
| Q2 2017 | $862,000 | -84.4% | 8,598 | -81.1% | 0.02% | -84.3% |
| Q1 2017 | $5,516,000 | +38.5% | 45,608 | +28.0% | 0.13% | +55.8% |
| Q4 2016 | $3,982,000 | – | 35,629 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 602,047 | $61,102,000 | 6.76% |
| FT Options LLC | 36,847 | $3,740,000 | 5.64% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,988,019 | $303,254,000 | 4.80% |
| FT Options LLC | 71,000 | $1,320,000 | 1.99% |
| Rock Springs Capital Management LP | 373,000 | $37,856,000 | 1.75% |
| Redmile Group, LLC | 338,536 | $34,358,000 | 1.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 362,724 | $36,813,000 | 1.66% |
| Ghost Tree Capital, LLC | 50,000 | $5,075,000 | 1.08% |
| Atika Capital Management LLC | 32,500 | $3,298,000 | 0.95% |
| Sivik Global Healthcare LLC | 25,000 | $2,537,000 | 0.86% |